Source: Medical Device Network

NeuraLight: New assessment tool for ALS based on abnormal eye movements

NeuraLight's oculometric platform is a viable adjunct assessment tool in ALS according to research. The post New assessment tool for ALS based on abnormal eye movements appeared first on Medical Device Network.

Read full article »

NeuraLight's Competitors | NeuraLight's News | NeuraLight's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

25-100

Co-Founder & CEO

Micha Breakstone

CEO Approval Rating

90/100

Neuralight is a Texas-based AI platform that offers solutions such as drug development and patient monitoring for treating patients with neurological disorders.